Snapdeal launches ‘Sanjeevani’ to connect patients with potential plasma donors nationwide

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...

Snapdeal, India’s largest value e-commerce company, today launched an initiative to connect COVID 19 patients with potential plasma donors. Using its wide reach in India across smaller towns & cities, Snapdeal has created an easy to use platform called “Sanjeevani” accessible via website and mobile app.

Patients and donors can register themselves with their mobile numbers/email ids and provide relevant information like blood group, location, age and donor recovery date. After registering, Snapdeal’s algorithm will look for relevant matches and connect patients with potential donors.

Sanjeevani was first launched to help the employees of Snapdeal find possible donors. But given that it has been especially hard to find eligible plasma donors at this time, Snapdeal has opened this platform for everyone.

Sanjeevani will also help raise awareness on the importance of plasma donation and encourage recovered COVID 19 patients to donate.

 

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »